Mostrando 1,041 - 1,060 Resultados de 27,972 Para Buscar '"melanoma"', tiempo de consulta: 0.35s Limitar resultados
  1. 1041
    “…We found that T-oligo-treated human melanoma (MM-AN) cells had decreased expression of vascular endothelial growth factor (VEGF), VEGF receptor 2, angiopoeitin-1 and -2 and decreased VEGF secretion. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  2. 1042
    “…We report a case of pulmonary malignant melanoma as a late metastatic manifestation of primary plantar malignant melanoma in a 61-year-old man who presented with hemoptysis; metastatic malignant melanoma of the lung occurred 12 years after resection of primary malignant melanoma of sole of the right foot.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  3. 1043
    “…BACKGROUND: The authors report a rare case of a patient with previously treated cutaneous malignant melanoma that recurred 1 year later as an intracranial meningioma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  4. 1044
  5. 1045
    “…Adoptive Cell Transfer (ACT) of Tumor-Infiltrating Lymphocytes (TIL) in combination with lymphodepletion has proven to be an effective treatment for metastatic melanoma patients, with an objective response rate in 50%–70% of the patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  6. 1046
  7. 1047
    “…Herein reported is a case of congenital malignant melanoma in a premature male baby from a 25-year-old healthy mother who was found to have hydramnios at the 29th week of gestation. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  8. 1048
    “…Identification of key enzymes regulating melanoma progression and drug resistance has the potential to lead to the development of novel, more effective targeted agents for inhibiting this deadly form of skin cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  9. 1049
  10. 1050
    por Flaherty, Keith T.
    Publicado 2011
    “…Melanoma is among the leading causes of years of life lost due to cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
  11. 1051
    “…Three hundred twenty-seven subjects with incident melanoma and 119 melanoma-free controls completed a structured interview assessing melanoma risk factors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 1052
    “…BACKGROUND: Vitiligo is a common toxicity associated with immunotherapy for melanoma. Cytotoxic T lymphocytes (CTLs) against melanoma commonly target melanoma-associated antigens (MAAs) which are also expressed by melanocytes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 1053
    “…To functionally clarify EphA2’s role in melanoma, we analyzed a panel of melanoma cell lines and found that EphA2 levels are elevated in a significant fraction of the samples. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 1054
    por Godechal, Quentin, Gallez, Bernard
    Publicado 2011
    “…The incidence of malignant melanoma, the most dangerous form of skin cancer, is rising each year. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 1055
    por Godar, Dianne E.
    Publicado 2011
    “…The incidence of cutaneous malignant melanoma (CMM) has been increasing at a steady rate in fair-skinned populations around the world for decades. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 1056
    “…We report a case of a giant melanoma on the back with a very extreme Breslow thickness. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 1057
  18. 1058
    “…Recently, advances have been made which are revolutionizing the standard of care for patients with BRAF mutant melanoma. This paper provides an overview on the pathogenic ramifications of mutant BRAF signaling, the latest molecular testing methods to detect BRAF mutations, and the most recent clinical data of BRAF pathway inhibitors in patients with melanoma and BRAF mutations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 1059
    “…Recent technological advances in cancer genomics make it possible to dissect complicated genomic aberrations of melanomas. In particular, several specific genomic aberrations including 11q13 amplification and KIT aberrations have been identified in acral melanomas. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 1060
    “…The examination of the phenotypic and (epi) genetic changes in cutaneous melanoma has identified several genes deemed central to the development and progression of melanoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS